PharmaCielo Ltd. PCLOF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.80% | -423.85% | 129.04% | -7.01% | 43.16% |
| Total Depreciation and Amortization | -88.12% | 99.71% | 408.58% | -70.49% | -30.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 135.08% | -1,576.63% | -80.92% | 17.61% | 106.05% |
| Change in Net Operating Assets | -299.61% | 106.59% | 84.26% | -262.22% | 99.75% |
| Cash from Operations | 93.95% | -814.21% | 114.86% | -267.55% | 754.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -98.94% | 552.70% | -110.05% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -98.94% | 552.70% | -110.05% | -- | -- |
| Total Debt Issued | 108.70% | -23.33% | 500.00% | -80.00% | -69.14% |
| Total Debt Repaid | -- | -100.00% | 102.78% | -60.53% | -2,468.43% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 106.92% | -53.65% | 106.83% | -69.43% | -809.26% |
| Foreign Exchange rate Adjustments | 192.47% | -487.50% | -76.24% | 773.33% | -123.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.86% | -946.58% | -87.11% | 627.62% | -316.35% |